RBC Europe’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-335
| Closed | -$203K | – | 1029 |
|
|
2021
Q3 | $203K | Buy |
335
+10
| +3% | +$6.05K | 0.01% | 301 |
|
|
2021
Q2 | $182K | Buy |
325
+300
| +1,200% | +$168K | 0.01% | 329 |
|
|
2021
Q1 | $11.8K | Sell |
25
-43
| -63% | -$20.3K | ﹤0.01% | 882 |
|
|
2020
Q4 | $32.9K | Buy |
68
+43
| +172% | +$20.8K | ﹤0.01% | 606 |
|
|
2020
Q3 | $14K | Hold |
25
| – | – | ﹤0.01% | 728 |
|
|
2020
Q2 | $15.6K | Hold |
25
| – | – | ﹤0.01% | 674 |
|
|
2020
Q1 | $12.2K | Hold |
25
| – | – | ﹤0.01% | 655 |
|
|
2019
Q4 | $9.39K | Sell |
25
-3
| -11% | -$1.13K | ﹤0.01% | 814 |
|
|
2019
Q3 | $7.77K | Buy |
28
+25
| +833% | +$6.94K | ﹤0.01% | 833 |
|
|
2019
Q2 | $939 | Hold |
3
| – | – | ﹤0.01% | 1013 |
|
|
2019
Q1 | $1.23K | Hold |
3
| – | – | ﹤0.01% | 1017 |
|
|
2018
Q4 | $1.12K | Hold |
3
| – | – | ﹤0.01% | 1021 |
|
|
2018
Q3 | $1.21K | Hold |
3
| – | – | ﹤0.01% | 1063 |
|
|
2018
Q2 | $1.04K | Hold |
3
| – | – | ﹤0.01% | 1079 |
|
|
2018
Q1 | $1.03K | Hold |
3
| – | – | ﹤0.01% | 1065 |
|
|
2017
Q4 | $1.13K | Hold |
3
| – | – | ﹤0.01% | 1078 |
|
|
2017
Q3 | $1.34K | Buy |
+3
| New | +$1.34K | ﹤0.01% | 1070 |
|